| Description |
xlvi, 480 pages : illustrations ; 27 cm |
| Series |
Methods of cancer diagnosis, therapy, and prognosis ; v. 6 |
|
Methods of cancer diagnosis, therapy, and prognosis ; v. 6
|
| Contents |
Part 1. Ovarian Cancer -- Identification of Biomarkers for Clear Cell Ovarian Adenocarcinoma -- Ovarian Carcinoma: Diagnostic Immunohistochemistry of MUCIN4 (MUC4) -- Distinguishing Benign from Malignant Complex Adnexal Masses in Ovarian Cancer: Two-Dimensional Power Doppler Imaging -- Distinguishing Benign from Malignant Complex Adnexal Masses in Ovarian Cancer: Two-Dimensional Power Doppler Imaging -- Subgroups of Ovarian Carinoma: Identification Using Differential Gene Expression -- Sertoliform Endometrioid Carcinoma of the Ovary: Diagnosis and Prognosis -- Role of MUC16 (CA125) in the Pathogenesis of Epithelial Ovarian Cancer -- Clear Cell Carcinoma of the Ovary: Prognosis Using Cytoreductive Surgery -- Advanced Ovarian Cancer: Prediction of Surgical Outcomes Using Computed Tomography -- Part 2. Renal Cancer -- Renal Cell Carcinoma: Follow-Up with Magnetic Resonance Imaging After Percutaneous Radiofrequency Ablation -- Metastatic Kidney Cancer: Treatment with Infusional Interleukin 2 Plus Famotidine -- Preoperative Treatment with Cytokines Followed by Surgery -- Metastatic Renal Cell Carcinoma: Use of Bcl-2 and Fas to Predict Responses to Immunotherapy -- Wilms Tumor: Prognosis Using Microvessel Density -- Part 3. Urogenitary Tract Cancer -- Adenomatoid Tumor of the Adrenal Gland: Differential Diagnosis Using Immunohistochemistry -- Testicular Cancer: Post-Chemotherapy Retroperitoneal Lymph Node Dissection -- Survivors of Germ- Cell Testicular Cancer: Increased Risk of Second Primary Tumors -- Part 4. Urinary Bladder Cancer -- Urothelial Bladder Cancer: Screening with Urine Based Tumor Markers -- Detection of OCT 4 in Bladder Cancer: Role of Cancer Stem Cell -- Part 5. Cervical Uterine Cancer -- Uterine Cervical Glandular Lesions: Differentiation Using Immunohistochemistry of Mucins -- Uterine Cervical Carcinoma: Preoperative Magnetic Resonance Imaging Staging -- Cancer Imaging and Intracavitary Brachytherapy for Cervical Cancer -- Cervical Cancer: Methods for Assessing the Quality of Life -- Cervical Cancer: Positron Emission Tomography and Positron Emission Tomography/Computed Tomography -- Endometrial Cancer: Indoleamine 2,3 Dioxygenase as a Prognostic Indicator |
|
Part 6. Skin Cancer -- Neurofibromatosis Type 1 Associated Malignant Melanoma: Molecular Evidence of Inactivation of the NF1 Gene -- Malignant Melanoma: Localisation and Characterization Using Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography -- Malignant Melanoma Versus Deep Penetrating Nevus: Diagnostic and Prognostic Immunohistochemistry of Dipeptidyl Peptidase IV (Methodology) -- Nonmelanoma Skin Cancer: Use of Epha1 Receptor as a Prognostic Marker -- Part 7. Leukemia -- Pretreated Chronic Lymphocytic Leukemia: Use of Alemtuzumab -- Part 8. Multiple Myeloma -- ImmunotherapeuticStrategies, Radiotherapy, and Targeted Radionuclide Therapy Approaches for the Treatment of Multiple Myeloma -- Part 9. Sarcoma -- Low Grade Fibromyxoid Sarcoma: Diagnosis by Detecting FUS-CREB3L2 Fusion Gene Using Reverse Transcription-Polymerase Chain Reaction -- Synovial Sarcoma: Role of TLE1 as a Diagnostic Immunohistochemical Marker -- The Immunohistochemistry of Kaposi's Sarcoma -- Synovial Sarcoma: Role of Immunohistochemistry and Molecular Genetics in Diagnosis and Prognosis -- Sarcoma: Treatment with Ecteinascidin-743 |
| Notes |
Formerly CIP. Uk |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record |
| Subject |
Cancer -- Diagnosis.
|
|
Cancer -- Treatment.
|
|
Urogenital Neoplasms -- diagnosis.
|
|
Neoplasms -- diagnosis.
|
|
Neoplasms -- therapy.
|
|
Urogenital Neoplasms -- therapy.
|
| Genre/Form |
Fiction.
|
| Author |
Hayat, M. A., 1940-
|
| LC no. |
2009929394 |
| ISBN |
9048129176 (hbk.) |
|
9789048129171 (hbk.) |
|
9789048129188 (ebook) |
|
